关于Certara
Certara 利用生物模拟软件、技术和服务加速药物研发,从而改变传统的药物研发方式。其客户包括超 2,600 家生物制药公司、学术机构和来自 70 个国家的监管机构。访问我们 www.certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
[email protected]
媒体联系人:
Alyssa Horowitz
[email protected]
Home / Press Release / Certara to Participate in Upcoming Investor Conferences
RADNOR, PA – 2026 年 2 月 27 日 — Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
Certara 利用生物模拟软件、技术和服务加速药物研发,从而改变传统的药物研发方式。其客户包括超 2,600 家生物制药公司、学术机构和来自 70 个国家的监管机构。访问我们 www.certara.com.
David Deuchler
Gilmartin Group
[email protected]
Alyssa Horowitz
[email protected]
